Clinical impact of primary tumour location, early tumour shrinkage, and depth of response in the treatment of metastatic colorectal cancer with first-line chemotherapy plus cetuximab or bevacizumab

The primary tumour location is an important prognostic factor for previously untreated metastatic colorectal cancer (mCRC). However, the predictive efficacies of primary tumour location, early tumour shrinkage (ETS), and depth of response (DpR) on mCRC treatment has not been fully evaluated. This st...

Descripción completa

Detalles Bibliográficos
Autores principales: Sagawa, Tamotsu, Sato, Yasushi, Hirakawa, Masahiro, Hamaguchi, Kyoko, Fukuya, Akira, Okamoto, Koichi, Miyamoto, Hiroshi, Muguruma, Naoki, Fujikawa, Koshi, Takahashi, Yasuo, Takayama, Tetsuji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7666202/
https://www.ncbi.nlm.nih.gov/pubmed/33188279
http://dx.doi.org/10.1038/s41598-020-76756-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7666202/
https://www.ncbi.nlm.nih.gov/pubmed/33188279
http://dx.doi.org/10.1038/s41598-020-76756-1

Ejemplares similares